|
ZW10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.67830000000247E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.766880E-04 |
| Normal-vs-Stage2 |
2.191000E-04 |
| Normal-vs-Stage3 |
1.237650E-04 |
| Normal-vs-Stage4 |
3.81869999999118E-06 |
| Stage1-vs-Stage2 |
2.717600E-01 |
| Stage1-vs-Stage3 |
4.061000E-01 |
| Stage1-vs-Stage4 |
8.088000E-02 |
| Stage2-vs-Stage3 |
6.754200E-01 |
| Stage2-vs-Stage4 |
6.146400E-01 |
| Stage3-vs-Stage4 |
3.266600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4741999999911E-05 |
| Normal-vs-AfricanAmerican |
2.024100E-02 |
| Normal-vs-Asian |
5.500800E-03 |
| Caucasian-vs-AfricanAmerican |
6.678200E-01 |
| Caucasian-vs-Asian |
7.137600E-01 |
| AfricanAmerican-vs-Asian |
8.860400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29890000000188E-06 |
| Normal-vs-Female |
5.175500E-04 |
| Male-vs-Female |
3.571600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.444500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.97846999999696E-05 |
| Normal-vs-Age(61-80Yrs) |
8.03260000000749E-05 |
| Normal-vs-Age(81-100Yrs) |
1.465640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.127010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.163000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.099600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.634800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.346400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.441000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.324400E-01 |
| Classical-VS-Follicular |
1.417130E-04 |
| Classical-VS-Other |
4.138000E-02 |
| Classical-VS-Normal |
1.835930E-03 |
| Tall-VS-Follicular |
3.003600E-02 |
| Tall-VS-Other |
8.098300E-02 |
| Tall-VS-Normal |
5.960500E-02 |
| Follicular-VS-Other |
5.334600E-01 |
| Follicular-VS-Normal |
5.65350000036879E-07 |
| Other-VS-Normal |
1.084220E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65559999998344E-06 |
| Normal-vs-N1 |
3.51360000000467E-05 |
| N0-vs-N1 |
3.347600E-01 |
|
|
